Business Imperatives
- A US-based pharma incorporation, with over 4 years of association with Freyr, approached us for end-to-end Regulatory support.
- Freyr managed client support and maintenance activities, overseeing surveillance across 70+ ANDA/NDAs with supplements and necessary documentation.
- Freyr initiated and monitored necessary Regulatory support, leading to seamless workload distribution for the client.
Objectives
The objective was to provide comprehensive support for ANDAs and NDAs submission, as well as to conduct end-to-end Regulatory operations for over 70 products across multiple therapeutic areas and product types.
Problem Statement
- A limited number of resources were available to look after Regulatory CMC activities due to a high attrition rate.
- Lack of expertise in the management of end-to-end Regulatory services.
- Inability to manage over 70+ ANDAs/NDAs lifecycle management with a limited number of RA CMC associates internally.